Trials / Completed
CompletedNCT01131754
Heparin 100U/L for Prevention of PVC Complications
STUDIO CLINICO RANDOMIZZATO SULL'UTILIZZO DI EPARINA PER LA PROFILASSI DELLA TROMBOFLEBITE DA CATETERE VENOSO PERIFERICO
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 214 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Flushes with saline solution are used for maintaining patency of peripheral intermittent intravenous catheters in many institution based on the results of previous studies showing that 10 U heparin/mL is not better than saline in this respect. The latest meta-analysis investigated also safety and efficacy of heparin concentrations of 100 U/ml used as an intermittent flush, but no firm conclusion was reached because of limitations of the few available studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | heparin 100U/L flushes | peripheral venous catheter flushing with 3 mL of a 100 U heparin/mL normal saline from mono-use vial (Epsodilave, Mayne Pharma, Naples, Italy) at the end of each drug infusion. Independently from the number of drug infusions, all patients will receive at least two catheter flushes every day. |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2009-08-01
- Completion
- 2009-09-01
- First posted
- 2010-05-27
- Last updated
- 2010-06-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01131754. Inclusion in this directory is not an endorsement.